BioPharma Credit (LON:BPCP) Trading Down 1.7% – Time to Sell?

BioPharma Credit PLC (LON:BPCPGet Free Report)’s stock price was down 1.7% on Wednesday . The stock traded as low as GBX 68.70 ($0.89) and last traded at GBX 68.70 ($0.89). Approximately 16,766 shares traded hands during mid-day trading, a decline of 63% from the average daily volume of 45,428 shares. The stock had previously closed at GBX 69.90 ($0.90).

BioPharma Credit Price Performance

The company has a market cap of £991.65 million, a PE ratio of 9.50 and a beta of 0.22. The business’s 50 day moving average is GBX 68.42 and its 200-day moving average is GBX 68.38.

BioPharma Credit Company Profile

(Get Free Report)

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.

Featured Stories

Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.